Fonterelli SPAC 2 Aktie
WKN DE: A3MQR6 / ISIN: DE000A3MQR65
08.10.2025 16:30:08
|
EQS-DD: Viromed Medical AG: Uwe Perbandt, sell
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
2. Reason for the notification a) Position / status
b) Amendment
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name
b) LEI
4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code
b) Nature of the transaction
c) Price(s) and volume(s)
d) Aggregated information
e) Date of the transaction
f) Place of the transaction
08.10.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Viromed Medical AG |
Hauptstraße 105 | |
25462 Rellingen | |
Germany | |
Internet: | https://www.viromed-medical-ag.de/ |
End of News | EQS News Service |
|
101084 08.10.2025 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Fonterelli SPAC 2 AG Inhaber-Aktmehr Nachrichten
16:31 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, buy (EQS Group) | |
16:31 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, Kauf (EQS Group) | |
16:30 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, sell (EQS Group) | |
16:30 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, Verkauf (EQS Group) | |
07.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, buy (EQS Group) | |
07.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, Kauf (EQS Group) | |
01.10.25 |
EQS-News: Viromed Medical AG drives forward market launch of new products in the first half of 2025 and expands strategic partnerships (EQS Group) | |
30.09.25 |
EQS-News: Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs (EQS Group) |
Analysen zu Fonterelli SPAC 2 AG Inhaber-Aktmehr Analysen
Aktien in diesem Artikel
Fonterelli SPAC 2 AG Inhaber-Akt | 4,46 | 1,36% |
|